Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Deferred Revenue: 2019

Historic Current Deferred Revenue for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2019 value amounting to -$2,340.

  • ADC Therapeutics' Current Deferred Revenue was N/A to -$2,340 in Q4 2019 from the same period last year, while for Dec 2019 it was -$2,340, marking a year-over-year change of. This contributed to the annual value of -$2,340 for FY2019, which is N/A change from last year.
  • ADC Therapeutics' Current Deferred Revenue amounted to -$2,340 in FY2019.
  • In the past 5 years, ADC Therapeutics' Current Deferred Revenue registered a high of -$2,340 during FY2019, and its lowest value of -$2,340 during FY2019.
  • In the last 1 years, ADC Therapeutics' Current Deferred Revenue had a median value of -$2,340 in 2019 and averaged -$2,340.